Better long-term survival in young and middle-aged women than in men after a first myocardial infarction between 1985 and 2006. an analysis of 8630 patients in the Northern Sweden MONICA Study by Isaksson, Rose-Marie et al.
RESEARCH ARTICLE Open Access
Better long-term survival in young and
middle-aged women than in men after a first
myocardial infarction between 1985 and 2006.
an analysis of 8630 patients in the Northern
Sweden MONICA Study
Rose-Marie Isaksson
1,2, Jan-Håkan Jansson
3,6, Dan Lundblad
4,6, Ulf Näslund
5,6, Karin Zingmark
7, Mats Eliasson
4,6*
Abstract
Background: There is conflicting and only scant evidence on the effect of gender on long-term survival after a
myocardial infarction (MI). Our aim was to analyse sex-specific survival of patients for up to 23 years after a first MI
in northern Sweden and to describe time trends.
Methods: The Northern Sweden MONICA Myocardial Infarction Registry was linked to The Swedish National Cause
of Death Registry for a total of 8630 patients, 25 to 64 years of age, 6762 men and 1868 women, with a first MI
during 1985-2006. Also deaths before admission to hospital were included. Follow-up ended on August 30, 2008.
Results: Median follow-up was 7.1 years, maximum 23 years and the study included 70 072 patient-years. During
the follow-up 45.3% of the men and 43.7% of the women had died. Median survival for men was 187 months
(95% confidence interval (CI) 179-194) and for women 200 months (95% CI 186-214). The hazard ratio (HR) for all
cause mortality after adjustment for age group was 1.092 (1.010-1.18, P = 0.025) for females compared to males, i.e.
9 percent higher survival in women. After excluding subjects who died before reaching hospital HR declined to
1.017 (95%CI 0.93-1.11, P = 0.7). For any duration of follow-up a higher proportion of women were alive,
irrespective of age group. The 5-year survivals were 75.3% and 77.5%, in younger (<57 years) men and women and
were 65.5% and 66.3% in older (57-64 years) men and women, respectively. For each of four successive cohorts
survival improved. Survival time was longer for women than for men in all age groups.
Conclusions: Age-adjusted survival was higher among women than men after a first MI and has improved
markedly and equally in both men and women over a 23-year period. This difference was due to lower risk for
women to die before reaching hospital.
Background
Mortality from myocardial infarction (MI) in Sweden, as
in most other developed countries, has decreased mark-
edly during recent decades [1]. The international MON-
ICA collaboration hypothesizes that the decline is
mainly due to a decrease in the classical risk factors –
smoking, cholesterol and blood pressure [2], although
recent modelling strongly emphasizes the pivotal role of
lower cholesterol [3]. However, MI still remains the
most common cause of death in Sweden and other wes-
tern regions [4]. Women are affected by MI later in life
than men. Below 55 years of age the risk of MI in men
is almost four times that of women [5]. With increasing
age, the incidence of MI increases markedly, but the
incidence and mortality from MI remain lower in
women throughout life [5].
Most studies of long-term survival after an MI have
had a follow-up time of maximum 5 years [6-10], only a
few have had a longer period [11-14]. Furthermore,
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[6,10,11,13,14]. Only few studies have documented the
impact of sex in long-term survival after an MI
[6,10,11,15]. Two of these studies from the 1990 s
[6,10] included first and recurrent MIs, had a short per-
spective and found no sex differences in the 30-day to
1-year mortalities. A Scottish study of 201 114 patients
with a first MI during the years 1986-1995, covering
also initial out-of-hospital deaths, showed that women
did not fare worse than men when age was taken into
account [15]. In an American study including 12 331
patients with both first and recurrent MIs, with a 6-year
follow-up, long-time survival was also similar between
the sexes [11].
No studies have investigated sex-specific time trends
in long-term mortality in patients with a first MI. As
there are important sex differences in mortality before
admission to hospital, men fare worse [15], such data
must be included to give the true picture of the total
mortality burden of ischemic heart disease (IHD). To
our knowledge only one study has taken a specific sex
and age approach when analysing trends in long-term
survival after a first MI [12]. This recently presented
Norwegian hospital-based study included 12 000
patients, divided into two age groups (<60 years,
>60 years) with a first MI. However, pre-hospital mor-
tality was not included. A substantial decline in long-
term mortality in both sex and age groups over 23
years was found but mortality did not differ between
men and women.
The aim of this study was to analyse sex-specific long-
term survival up to 23 years in patients below 65 years
of age with a first MI during 1985-2006 in northern
Sweden. In addition, we aimed to study if trends over
time differed between sexes.
Methods
This study relies on two separate registries in Sweden:
The Northern Sweden MONICA Myocardial Infarction
Registry and The Swedish National Cause of Death
Registry.
The WHO MONICA project (Monitoring Trends and
Determinants in Cardiovascular Disease) started in the
beginning of the 1980 s. The Northern Sweden MON-
ICA Study is ongoing in Västerbotten and Norrbotten
counties since 1985. The Myocardial Infarction Registry
includes cases based on the MONICA criteria [16].
The registry is population based, which means that all
MI events are included, not only those who are
admitted to hospital. Most importantly, all deaths out of
hospital are evaluated for possible myocardial infarction.
The case findings of possible events are based mainly on
two sources, hospital discharge registries and death
certificates. To validate the diagnosis of MI, medical
history, clinical symptoms, ECG and cardiac enzymes
are used based on strict WHO MONICA criteria
throughout the period. MI diagnoses are based on typi-
cal symptoms and biomarkers for myocardial necrosis. If
only one of these parameters is positive, ECG analysis is
included for final diagnosis.
In fatal cases, information obtained from death certifi-
cates and necropsy reports, when available, is also
included. In fatal events, possible infarction and unclas-
sifiable infarctions are included, according to the inter-
national MONICA protocol. An event is considered first
ever if the history according to the hospital records and
the MONICA database is free from previous clinically
recognized MI, otherwise the event is considered as
recurrent [16]. Since 2000 all the reporting hospitals
have switched to the use of troponins, and the local
reference values are applied.
During the study period from January 1, 1985 to
December 31, 2006, a total of 12 635 patients who ful-
filled the MONICA criteria and diagnosed as a definite
MI were registered in the MONICA myocardial infarc-
tion registry. In this study only first ever MIs in subjects
25-64 years of age were included. Hence, a total of 8630
patients were included. The population at-risk in the
area was 258 576 (December 31, 2009). Data on clinical
characteristics were not routinely registered before 1989.
All patients were followed up for information on vital
status using The Swedish Cause of Death Registry until
August 30, 2008. Patients not identified in the register
were assumed to be alive at that date and censored. It is
estimated that 93% of all deaths are reported to Statis-
tics Sweden within 10 days and 100% within 30 days
using the unique personal identification number (PIN)
assigned to every citizen in Sweden [17]. The two regis-
tries (MONICA and The Cause of Death Registry) were
linked by the PIN. The endpoint studied was death from
any cause, i.e. all cause mortality.
Ethical considerations
The Northern Sweden MONICA Study was approved by
the Research Ethics Committee of Umeå University, and
the data handling procedures were approved by the
National Computer Data Inspection Board. Participants
or relatives to nonsurvivors gave written consent.
Statistical analyses
Separate groups according to age at onset were con-
structed to achieve groups of similar size: 25-50 years,
51-56 years, 57-60 years and 61-64 years for men and
women. The patients were separated into four cohorts
representing the year of onset of MI: 1985-1988, 1989-
1994, 1995-2000 and 2001-2006. Survival time was cal-
culated as the number of days between the date of the
MI and the date of death, or August 30, 2008.
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duct limit estimate. Hypothesis test of no difference in
survival was calculated by Cox regression analysis, with
adjustment for age group. For explanatory reasons we
performed a sensitive analysis by omitting those who
died out of hospital and repeated the survival analysis.
All analyses were carried out using the statistical com-
puter program PASWStatistics 18.
Results
A total of 8630 subjects, 6762 men and 1868 women, with
a first MI between 1985 and 2006, were included. Mean
age for men was 55.5 years and for women 56.4 years.
Clinical characteristics are shown in Table 1. No data,
except age, were available for the first period, and missing
data ranged from 1 to 16%. Age at onset was stable for
men but declined slightly among women over time.
Previous known ischaemic heart disease (i.e.a n g i n a
pectoris) was initially more common among men and
then similar between the sexes. The prevalence of
hypertension declined but was more common among
women during the whole study period. Known diabetes
was more common among women and increased some-
what over time. Regular smoking was much more com-
mon and increased among women, while it was stable
in men. No data were available on the prevalence of
hyperlipidaemia or treatment with lipid-lowering drugs.
Median follow-up was 85 months (7.1 years) and max-
imum 288 months (24 years). Total follow-up was 70
002 patient-years. During the follow-up a total of 3066
(45.3%) of the men and 798 (42.7%) of the women died.
Among men 959 (14.2%) died before admission to hos-
pital and among women 205 (11.0%). Mean age for
those who died before reaching hospital was 56.0 years
for men and 57.1 years for women.
Survival according to sex
In a Cox regression analysis the hazard ratio (HR) for
all-cause mortality, after adjustment for age group, was
1.09 (95%CI 1.010-1.18, P = 0.025) for females vs. males,
i.e. 9 percent higher survival in women than in men. An
analysis using age and year of onset as time-dependent
variables gave the same results (data not shown). After
excluding subjects who died before reaching hospital
HR declined to 1.017 (95%CI 0.93-1.11, P = 0.7).
Median survival for men was 187 months (95% CI 179-
194) and for women 200 months (CI 186-214) (Figure 1).
I nT a b l e2t h ep r o p o r t i o n st h a tw e r ea l i v ea t7d a y s ,2 8
days, 1, 3, 5, 10 and 20 years after their MI are presented,
stratified for age. For any duration of follow-up a higher
proportion of women were alive, irrespective of age group.
As the median follow up was 7.1 years figures on 5-year
survival will include most subjects. Five years after a first
MI 75.3% and 77.5%, among younger (<57 years) men and
women were alive, and 65.5% and 66.3% in older (57-64
years) men and women were alive, respectively. After
excluding subjects who died before reaching hospital med-
ian survival for men was 225 months (95% CI 217-233)
and for women 222 months (95% CI 207-236).
Survival according to age group
In each age group women had a longer median survival
than men (Table 3, Figure 2). Survival was shorter with
higher age.
Survival according to cohort
For each cohort survival increased (Figure 3). During the
first and third periods survival in women exceeded that
of men, while the reverse was true for the second per-
iod, and no difference was seen during the last period
(Table 1, Figure 4).
Table 1 Clinical characteristics at baseline of men and women with a first myocardial infarction during four
consecutive time periods, 1985 to 2006*
1985-1988 1989-1994 1995-2000 2001-2006 1985-2006
Men N 1463 1927 1711 1662 6763
Survived (%) 408 (27.8) 903 (46.9) 1092 (63.8) 1296 (78.0) 3697 (54.7)
Age (%) 55.60 55.30 55.30 55.70 55.50
IHD (%) 355 (30.1) 520 (31.3) 412 (25.3) 1287 (28.8)
Hypertension (%) 782 (42.6) 531 (33.4) 598 (36.9) 1911 (37.9)
Diabetes (%) 221 (11.6) 242 (14.2) 262 (15.9) 725 (13.8)
Regular smoking (%) 683 (38.2) 545 (43.0) 516 (38.2) 1744 (39.6)
Women N 350 509 495 514 1868
Survived (%) 101 (28.9) 230 (45.2) 338 (68.3) 401 (78.0) 1070 (57.3)
Age 57.10 56.50 55.90 56.20 56.40
IHD (%) 86 (27.5) 138 (29.0) 127 (25.2) 351 (27.2)
Hypertension (%) 247 (50.9) 196 (42.4) 231 (47.2) 674 (46.9)
Diabetes (%) 82 (16.3) 71 (14.4) 97 (18.9) 250 (16.6)
* Missing data: IHD 15.5%, hypertension 5%, diabetes 0.6%, smoker 16%.
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Between 1985 and 2006 long-term survival after a first
MI has increased in both men and women between 25
and 64 years of age in northern Sweden. Over the whole
23-year period women showed a nine percent higher
survival than men. This difference was due to lower risk
for women to die before reaching hospital, and during
the last period similar rates of long time survival were
noted in men and women.
During the last two decades differences in outcome
between men and women suffering an MI have been
increasingly highlighted. Still the evidence is conflicting
regarding gender specific outcomes and prognosis after
MI. Comparison between studies is complicated by
methodological differences such as differences in data
collection, registration methods, study population, case
definition and research period. However, no study has
previously presented data from such a large database as
the Northern Sweden MONICA Study, over such a long
time as 23 years, including exclusively patients with
their first MI, and including also patients who died
before reaching the hospital.
Improvement in long-term survival after a first MI is
probably attributable to a combination of better treat-
ment before admission to hospital by paramedics,
improvements in the acute coronary care, and secondary
prevention. Over the study period there was an increas-
ing use of evidence-based medical treatments and cor-
onary artery revascularisation at the onset of MI, all of
which have been shown to reduce cardiac morbidity and
mortality [18]. Secondary prevention programmes and
Figure 1
Figure 1 Median survival after a first myocardial infarction according to sex.
Table 2 Proportion of men and women surviving after a
first myocardial infarction stratified for age
Survival (%) at different times after MI
Men Women
Time after
MI
Age 25-55
years
Age 56-64
years
Age 25-55
years
Age 56-64
years
7 days 82.2 77.6 85.2 79.1
28 days 81.2 74.9 82.9 76.9
1 years 79.2 72.3 81.4 73.5
3 years 77.3 68.9 79.3 69.9
5 years 75.3 65.5 77.5 66.3
10 years 71.0 58.0 75.1 59.8
20 years 63.9 48.9 69.7 51.2
Table 3 Median survival in men and women after a first
MI according to age group
Survival (months)
Age at onset Sex Median
25-50 Men 278
Women NA
51-56 Men 217
Women 250
57-60 Men 177
Women 192
61-64 Men 115
Women 136
25-64 Men 187
Women 200
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of MI patients in Sweden. Since the early nineties all
patients have been called and invited for individual
counselling by cardiologists or dedicated nurses, for
educational programs and for exercise programs in
groups. Prescriptions for platelet inhibitors, beta-blockers,
ACE-inhibitors and statins have increased in parallel with
evidence and publications of landmark studies [3]. The
attendance rate at clinical follow-up after an MI in Swe-
den has been generally high, approximately 80-90%,
although patients with lower socioeconomic status have
had a lower participation rate.
The increased long-term survival as shown in our
study also reflects the forceful implementation of pri-
mary and secondary prevention of MI which has been
shown in a recently published modelling study from
Sweden [3]. Approximately 36% of the decrease in mor-
t a l i t yi nc o r o n a r yh e a r td i s e a s ed u r i n g1 9 8 6 - 2 0 0 2w a s
due to treatment of individuals and 55% was due to
population risk factor reductions including total choles-
terol, smoking and blood pressure levels. The substantial
reduction in total cholesterol level explained almost 40%
of the decrease, and almost 10% of the mortality reduc-
tion came from a decline in smoking prevalence.
Interestingly, during the studied 23-year period, the
incidence of first MI before the age of 65 years in north-
ern Sweden decreased among men but was unchanged
among women [16]. In the Northern Sweden MONICA
study we recently presented data on time trends in
major cardiovascular risk factors from six population
surveys covering the same population and time period
as the MI registry. Significant improvements were
observed in the control of hypertension, smoking, and
an increased level of education between 1986 and 2009
noted [19]. In spite of increasing BMI no increase in the
prevalence of diabetes was found. Total cholesterol
Figure 2 Survival after a first myocardial infarction according to sex and age group.
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Figure 4 Survival after a first myocardial infarction according to sex and year of onset.
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which is likely to have a major impact on the improved
prognosis over time. Lower risk factor levels were
achieved in both men and women although the decline
in smoking was much slower in women. In 2009 more
women than men were still regular smokers. This may
be a factor behind our finding of no difference between
men and women during our last observation period.
During the last two decades there has been an
ongoing debate about the differences between men and
women suffering from MI in terms of treatment and
outcome [20,21]. It has been repeatedly stated that
women with MI are treated less aggressively than men
and that reperfusion therapy is under-utilized in
women with MI [22]. Women are also said to be less
likely to be referred for coronary angiography and
revascularization procedures such as percutaneous cor-
onary interventions and coronary artery bypass grafting
[23]. However, one recent Swedish study with 1744
patients reported that men and women were treated
similarly [24].
Our results do not support the contention that the
outcome of a first MI in women is worse than in men.
On the contrary, we found a slightly longer median sur-
vival and higher probability of being alive during long-
term follow-up in accordance with recent large studies
[11,12,15]. Excluding subjects dead before arrival to hos-
pital abolished all gender differences but women still did
not fare any worse than men. This was expected, as it
was previously known that men had a higher proportion
of out-of-hospital deaths. This has important implica-
tions for interpretation of studies based solely on those
admitted to hospital in which an apparent worse prog-
nosis for women has been evident. It also underscores
the unique properties of the Northern Sweden MON-
I C Ar e g i s t r ym i r r o r i n gt h et o t a lm o r t a l i t yb u r d e no fa
first MI in the society.
The reasons for the difference in long-term outcome
between men and women are unclear but higher fatality
in men before reaching of hospital surely contributes.
Further explanations to a great extent are speculative.
We had no data on severity of the MI which may be a
link in the causal chain leading to somewhat better
prognosis for women. Still, the sex-differences in this
study underscore the importance of a gender perspective
on all parts of the MI-journey, including symptom
representation and recognition, reasons for delay, diag-
nosis, treatment and long-term outcome.
There is clear evidence that early treatment, especially
within the first “golden hour” results in a considerable
survival benefit [25]. There are conflicting data regard-
ing whether there are gender differences in clinical man-
ifestations and delay before seeking treatment for acute
cardiac symptoms. However, in Northern Sweden we
found no major gender differences in type of symptoms
or time between onset and medical presence as defined
in the WHO MONICA manual based on the same
population as the present study [26].
Strengths and limitations
The major strengths of our study was the large number
of patients studied over such a long period, 23 years,
which is longer than most studies. When analysing mor-
tality from MI it is not enough to analyse in-hospital
mortality. A considerable proportion of deaths from MI
occur outside hospital. We also included deaths before
admission, thereby accurately describing the total bur-
den of disease. The validity of our findings is strength-
ened by the strict and uniform use of the MONICA
criteria over the whole period. It should also be noted
that this is not a random sample from the population.
The Northern Sweden MONICA registry includes all
those who suffered an MI in the defined geographical
area with no loss to follow-up.
The main limitation and a major drawback of this
study is the upper age limit chosen in the WHO MON-
ICA project. When the project was initiated in the early
1980 s, the focus was on what was regarded as premature
cardiovascular disease. Therefore, an upper age limit was
set at 65 years. Thus, the results cannot be extrapolated
to older age groups or to the total population.
Another limitation of the present study is the introduc-
tion of troponins (in the 1990 s) as markers of myocardial
injury. These markers were not included in the original
MONICA criteria from the early eighties for validation
and classification of events. This means that MI definitions
before and after the year 2000 differ to some extent. It is
complicated to handle this situation when all the hospitals
in Sweden changed their diagnostic markers and stopped
using the older biomarkers that were described in the
MONICA project. Our analysis [16] suggests that this may
be the reason for the attenuated decline in incidence of
MI noted after 2000, but no impact was noted on case-
fatality (i.e. proportion dead after 28 days). The switch to
troponins would not affect the large proportion of subjects
dead before hospital, nor is it probable that the effect
would be differential according to sex and thus invalidate
our findings.
Conclusions
We conclude that over a 23-year period the age-adjusted
survival after a first MI below the age of 65 years is
higher among women than among men due to lower
risk for women to die before reaching hospital. Survival
is similar in those having an MI after 2000. For both
men and women survival improved impressively.
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